A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to ...

New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...

A new study shows that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...

Kura Oncology's ziftomenib shows promise in AML treatment, with FDA Priority Review ahead. Read here for an analysis of KURA ...

A groundbreaking NHS therapy for myeloma uses a 'Trojan horse' approach to target cancer cells, offering longer remission, ...

Little is known about what causes ovarian cancer, and there is no way to detect it early yet. About 75% of the time when ...

A new AI tool, AAnet, has discovered five distinct cell types within tumors, offering a deeper look into cancer's inner diversity. This insight could transform how we treat cancer, enabling more ...

Brazilian scientists have identified a molecule, BamazScplp1, in Amazonian scorpion venom that effectively kills breast ...

Monotherapy efficacy and safety profile provided backbone for clinical development strategy in 1L combination with nivolumab plus chemotherapy ...

ABBV-706 is an ADC targeting SEZ6 developed by AbbVie. It is linked to a topoisomerase 1 inhibitor (TOP1i) via a ...

Ribosomes are tiny molecular machines inside all living cells that build proteins, and ribosome biogenesis is the complex, ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...